1993R0302 — EN — 01.10.2003 — 003.001 — 1
This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents
►B COUNCILREGULATION(EEC)No302/93
of8February1993
ontheestablishmentofaEuropeanMonitoringCentreforDrugsandDrugAddiction
(OJ L 36, 12.2.1993, p. 1)
Amended by:
Official Journal
No page date
►M1Council Regulation (EC) No 3294/94 of 22 December 1994 L 341 7 30.12.1994
►M2Council Regulation (EC) No 2220/2000 of 28 September 2000 L 253 1 7.10.2000
►M3Council Regulation (EC) No 1651/2003 of 18 June 2003 L 245 30 29.9.2003
Corrected by:
►C1Corrigendum, OJ L 121, 1.5.2001, p. 48 (2220/2000)
▼B
COUNCILREGULATION(EEC)No302/93
of8February1993
on the establishment of a European Monitoring Centre for Drugs
andDrugAddiction
THE COUNCIL OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Economic
Community, and in particular Article 235 thereof,
Having regard to the proposal from the Commission (1),
Having regard to the opinion of the European Parliament (2),
Having regard to the opinion of the Economic and Social
Committee (3),
Whereas, at its meeting in Dublin on 25 and 26 June 1990, the
European Council:
— ratified the ‘Guidelines for a European Plan to Combat Drugs’
submitted to it by the European Committee to Combat Drugs(Celad), and in particular the recommendation that ‘a study beconducted by experts on the existing sources of information, theirreliability and their usefulness, and on the need for and possiblescope of a European Drugs Monitoring Centre and the financial
implications of setting up such a Centre, on the understanding that
the brief of this Centre would cover not only the social and healthaspects but also other drugs-related aspects, including traffickingand repression’,
— stressed that it was the responsibility of each Member State to
develop an appropriate drug demand reduction programme and
considered that effective action by each Member State, supported
by joint action of the Twelve and the Community, should be amain priority over the coming years;
Whereas the findings of the feasibility study on the Centre and the
European Plan to Combat Drugs submitted to the Rome European
Council on 13 and 14 December 1990 should be borne in mind;
Whereas the European Council, at its meeting in Luxembourg on 28
and 29 June 1991, ‘approved the setting up of a European Drugs Moni-toring Centre on the understanding that the practical arrangements forits implementation, e.g. its size, institutional structure and computer
systems, are still to be discussed and instructed Celad to continue
work to that end and bring it rapidly to a successful conclusion, inliaison with the Commission and the other relevant political bodies’;
Whereas the European Council, at its meeting in Maastricht on 9 and
10 December 1991, ‘invited the institutions of the Community to
employ all means to ensure that the act setting up the European Drugs
Centre could be adopted before 30 June 1992’;
Whereas the Community concluded, by Decision 90/611/EEC (
4), the
United Nations Convention against Illicit Traffic in Narcotic Drugsand Psychotropic Substances, hereinafter referred to as the ‘Vienna
Convention’, and deposited a declaration of competence regarding
Article 27 thereof (
5);
Whereas the Council adopted Regulation (EEC) No 3677/90 (6) for the
implementation by the Community of the system provided for inArticle 12 of the aforementioned Vienna Convention for monitoringtrade in certain substances;1993R0302 — EN — 01.10.2003 — 003.001 — 2
(1) OJ No C 43, 18. 2. 1992, p. 2.
(2) OJ No C 150, 15. 6. 1992, p. 54.
(3) OJ No C 223, 31. 8. 1992, p. 26.
(4) OJ No L 326, 24. 11. 1990, p. 56.
(5) OJ No L 326, 24. 11. 1990, p. 57.
(6) OJ No L 357, 20. 12. 1990, p. 1. Regulation, as amended by Regulation
(EEC) No 900/92 (OJ No L 96, 10. 4. 1992, p. 1).
▼B
Whereas the Council adopted Directive 91/308/EEC of 10 June 1991
on prevention of the use of the financial system for the purpose ofmoney laundering (
1), which aims in particular to combat drug traf-
ficking;
Whereas objective, reliable and comparable information concerning
drugs, drug addiction and their consequences is required at Community
level to helpp rovide the Community and the Member States with anoverall view and thus give them added value when, in their respectiveareas of competence, they take measures or decide on action to combatdrugs;
Whereas the drug phenomenon comprises many complex and closely
interwoven aspects which cannot easily be dissociated; whereas, there-fore, the Centre should be entrusted with the task of furnishing overallinformation which will helpto p rovide the Community and its Member
States with an overall view of the drug and drug addiction phenom-
enon; whereas this task should not prejudice the allocation of powersbetween the Community and its Member States with regard to thelegislative provisions concerning drug supply and demand;
Whereas the Centre's organization and working methods must be
consistent with the objective nature of the results sought, namely thecomparability and compatibility of sources and methods in connectionwith drug information;
Whereas the information compiled by the Centre will concern priority
areas whose content, scope and implementing arrangements should bedefined;
Whereas, during the first three-year period, special attention will be
given to demand and demand reduction;
Whereas, in their resolution of 16 May 1989 concerning a European
network of health data on drug abuse (
2), the Council and the Ministers
for Health of the Member States meeting within the Council invited theCommission to take possible initiatives in this area;
Whereas a European information network on drugs and drug addiction
should be set up, to be coordinated and led at Community level by the
European Drugs Monitoring Centre;
Whereas Convention 108 of the Council of Europe for the Protection of
Individuals with regard to Automatic Processing of Personal Date
(1981) should be taken into account;
Whereas there already exist national, European and international orga-
nizations and bodies supplying information of this kind, and whereas
the Centre should be able to carry out its tasks in close cooperation
with them;
Whereas the Centre must have legal personality;
Whereas it is necessary to ensure that the Centre carries out its infor-
mation task and to confer jurisdiction for this purpose on the Court ofJustice;
Whereas it is desirable to recognize the possibility of opening the
Centre to non-Community countries which share the interest of theCommunity and the Member States in the attainment of these objec-
tives, under agreements to be concluded between them and the
Community;
Whereas this Regulation could, if necessary, be adapted after a three-
year period with a view to a decision on the possible extension of theCentre's tasks, taking into account, in particular, the evolution ofCommunity powers;
Whereas, for the adoption of this Regulation the Treaty provides for no
powers to act other than those laid down in Article 235,1993R0302 — EN — 01.10.2003 — 003.001 — 3
(1) OJ No L 166, 28. 6. 1991, p. 77.
(2) OJ No C 185, 22. 7. 1989, p. 1.
▼B
HAS ADOPTED THIS REGULATION:
Article 1
Objective
1. This Regulation establishes the European Monitoring Centre for
Drugs and Drug Addiction (EDMC), hereinafter referred to as ‘theCentre’.
2. The Centre's objective is to provide, in the areas referred to in
Article 4, the Community and its Member States with objective, reli-
able and comparable information at European level concerning drugs
and drug addiction and their consequences.
3. The statistical, documentary and technical information processed
or produced is intended to help provide the Community and theMember States with an overall view of the drug and drug addiction
situation when, in their respective areas of competence, they take
measures or decide on action.
4. Without prejudice to Article 2(D)14, the Centre may not take any
measure which in any way goes beyond the sphere of information and
the processing thereof.
5. The Centre shall not collect any data making it possible to iden-
tify individuals or small groups of individuals. It shall refrain from any
transmission of information relating to specific named cases.
Article 2
Tasks
In order to achieve the objective set out in Article 1, the Centre shall
perform the following tasks within its areas of activity:
A.Collection and analysis of existing data
It shall:
1. collect, register and analyse information, including data resulting
from research, communicated by Member States as well as thatemanating from Community, non-governmental national sourcesand competent international organizations;
2. carry out surveys, preparatory studies and feasibility studies,
together with any pilot projects necessary to accomplish itstasks; organize meetings of experts and whenever necesssary setupad hocworking parties for the purpose; it shall set up and
make available open scientific documentation resources and
assist in the promotion of information activities;
3. provide an organizational and technical system capable of
supplying information on similar or complementary programmes
or action pursued by the Member States;
4. establish and coordinate, in consultation and in cooperation with
the competent authorities and organizations in the Member
States, the network referred to in Article 5;
5. facilitate exchanges of information between decision-makers,
researchers, specialists and those involved in combating drugs
in governmental and non-governmental organizations;
B.Improvement of data-comparison methods
6. ensure improved comparability, objectivity and reliability of data
at European level by establishing indicators and common criteriaof a non-binding nature, compliance with which may be recom-mended by the Centre, with a view to greater uniformity of themeasurement methods used by the Member States and the
Community;
7. facilitate and structure exchange of information, in terms of both
quality and quantity (databases);1993R0302 — EN — 01.10.2003 — 003.001 — 4
▼M2
▼B
▼B
C.Dissemination of data
8. make the information produced by it available to the Commu-
nity, the Member States and competent organizations;
9. ensure wide dissemination of work done in each Member State
and by the Community itself, and, where appropriate, by non-
Community countries or international organizations;
10. ensure wide dissemination of reliable non-confidential data, on
the basis of data which it gathers it shall publish a yearly reporton the state of the drugs problem;
D.Cooperation with European and international bodies and organiza-
tions and with non-Community countries
11. contribute to improving coordination between national and
Community action in its areas of activity;
12. without prejudice to Member States' obligations with regard to
transmission of information under the provisions of the UnitedNations Conventions on drugs, promote the incorporation ofdata on drugs and drug addiction gathered in the Member States
or emanating from the Community into international monitoring
and drug-control programmes, particularly those established bythe United Nations Organization and its specialized agencies;
13. cooperate actively with the bodies referred to in Article 12;
14. It may transfer in applicant countries and in countries eligible
for the PHARE programme, at the request of the Commissionof the European Communities, its know-how and assist in thecreation and reinforcement of structural links with the Reitox
network and the setting upand the consolidation of the national
focal points.
Article 3
Workmethod
1. The Centre shall progressively carry out its tasks in the light of
the objectives adopted in the three-year and annual work programmes
and with due regard to the available resources.
2. In pursuing its activities, the Centre shall, in order to avoid dupli-
cation, take account of those already carried out by other existing or
future institutions and agencies, notably the European Police Office
(Europol), and shall ensure that it adds to their value.
Article 4
Priority areasofactivity
The objectives and tasks of the Centre, as defined in Articles 1 and 2,
shall be implemented following the order of priorities indicated in theAnnex.
Article 5
European Information Network on Drugs and Drug Addiction
(Reitox)
1. The Centre shall have at its disposal the European Information
Network on Drugs and Drug Addiction (Reitox), a computer network
forming the infrastructure for collecting and exchanging information
and documentation; the network shall make use of, inter alia, an auton-
omous computer system linking the national drug informationnetworks, the specialized centres in Member States and the informationsystems of the international or European organizations or bodies coop-
erating with the Centre.
2. In order to enable the network to be established as rapidly and
efficiently as possible, the Member States shall, with in six months of1993R0302 — EN — 01.10.2003 — 003.001 — 5
▼M2
▼C1
▼B
▼B
the entry into force of this Regulation, notify the Centre of the main
elements of their national information networks, including whereappropriate the national monitoring centres, in the areas of activity
mentioned in Article 4 and name any specialized Centres which in their
judgment could make a useful contribution to the Centre's work.
3. The specialized centres shall be designated with the consent of
the Member State in whose territory they are located, by a unanimous
decision of the members of the management board, as referred to in thesecond subparagraph of Article 8 (2), for a period not exceeding theduration of each multiannual work programme as referred to in Article8 (3). This designation shall be renewable.
4. The Centre may, with the consent of the Member State in whose
territory the centres are located, enter into contractual relations, inparticular subcontracting arrangements, with governmental or non-
governmental specialized centres as referred to in paragraph 3, in order
to fulfil any tasks which it may wish to entrust to them. With theconsent of the respective Member States, it may also enter intocontracts, on an ad hocbasis and for specific tasks, with bodies which
are not part of Reitox.
5. The allocation of specific tasks to the specialized centres shall
appear in the Centre's multiannual programme mentioned in Article 8(3).
Article 6
Protection andconfidentiality ofdata
1. Where on the basis of this Regulation personal data which do not
enable natural persons to be identified are also forwarded to the Centrein accordance with national law, such data may be used only for thestated purpose and under the conditions prescribed by the forwarding
authority. This shall apply mutatis mutandis where personal data are
communicated by the Centre to the competent authorities of theMember States or to international organizations and other Europeaninstitutions.
2. Data on drugs and drug addiction provided to or by the Centre
may be published subject to compliance with Community and nationalrules on the dissemination and confidentiality of information. Personaldata may not be published or made accessible to the public.
3. Member States and the specialized centres shall be under no obli-
gation to provide information classified as confidential under theirnational legislation.
Article 6a
Accesstodocuments
1. Regulation (EC) No 1049/2001 of the European Parliament and
of the Council of 30 May 2001 regarding public access to EuropeanParliament, Council and Commission documents (
1) shall apply to
documents held by the Centre.
2. The Management Board shall adopt the arrangements for imple-
menting Regulation (EC) No 1049/2001 within six months of entryinto force of Council Regulation (EC) No 1651/2003 of 18 June 2003amending Regulation (EEC) No 302/93 on the establishment of a
European Monitoring Centre for Drugs and Drugs Addiction (
2).
3. Decisions taken by the Centre pursuant to Article 8 of Regulation
(EC) No 1049/2001 may give rise to the lodging of a complaint to the
Ombudsman or form the subject of an action before the Court of
Justice, under the conditions laid down in Articles 195 and 230 of theTreaty respectively.1993R0302 — EN — 01.10.2003 — 003.001 — 6
(1) OJ L 145, 31.5.2001, p. 43.
(2) OJ L 245, 29.9.2003, p. 30.▼M3
▼B
Article 7
Legalstatus
The Centre shall have legal personality. It shall enjoy, in each Member
State, the most extensive legal status granted to legal persons undertheir laws; in particular, it may purchase or dispose of movable and
immovable property and may institute legal proceedings.
Article 8
ManagementBoard
1. The Centre shall have a management board consisting of one
representative from each Member State, two representatives from theCommission and two scientists particularly qualified in the field ofdrugs, designated by the European Parliament on the basis of their
particular qualification in that field.
Each member of the management board may be assisted or represented
by an alternative member. In the absence of the full member, the alter-native member may exercise his right to vote. The management board
may call in as non-voting observers representatives of international
organizations with which the Centre cooperates in accordance withArticle 12.
2. The chairman of the management board shall be elected by its
members for a three-year period: his term of office shall be renewable
once. The chairman shall take part in the voting. Each member of themanagement board shall have one vote.
The decisions of the management board shall be taken by a two-thirds
majority of its members, except in the cases referred to in Article 5 (3),
for which a unanimous decision by the members is required, and inparagraph 3 of this Article.
The management board shall draw upits own rules of p rocedure.
The management board shall meet at least once a year.
3. The management board shall adopt a three-year work programme
on the basis of a draft submitted by the Centre's Director, after
consulting the Scientific Committee and seeking the opinions of theCommission and of the Council. The first three-year programme shallbe adopted unanimously, within nine months of the entry into force ofthis Regulation. The management board, acting by a majority of three-quarters of its members, shall decide whether subsequent three-year
programmes are to be adopted by the majority laid down in the second
subparagraph of paragraph 2 of this Article or by unanimity.
4. Under the three-year work programme, the management board
shall each year adopt the Centre's annual work programme on the basis
of a draft submitted by the Director, after consulting the Scientific
Committee and seeking the Commission's opinion. The programmemay be adjusted in the course of the year in accordance with thesame procedure.
5. The Management Board shall adopt the annual report on the
Centre's activities and forward it by 15 June at the latest to the
European Parliament, the Council, the Commission, the Court of Audi-
tors and the Member States.
6. The Centre shall forward annually to the budgetary authority any
information relevant to the outcome of the evaluation procedures.1993R0302 — EN — 01.10.2003 — 003.001 — 7
▼M3
▼B
Article 9
Director
1. The Centre shall be headed by a Director appointed by the
management board on a proposal from the Commission for a five-yearperiod, which shall be renewable. The Director shall be responsible for:
— preparing and implementing the decisions and programmes adopted
by the Centre's management board,
— day-to-day administration,
— preparing the Centre's work programmes,
— the preparation of the draft estimate of the Centre's revenue and
expenditure and the implementation of the budget,
— the preparation and publication of the reports provided for in this
Regulation,
— all staff matters,
— performance of the tasks referred to in Article 1 and 2.
2. The Director shall be accountable for his activities to the manage-
ment board and shall attend its meetings.
3. The Director shall be the Centre's legal representative.
Article 10
Scientific Committee
1. The management board and the Director shall be assisted by a
Scientific Committee which shall deliver an opinion where providedfor in this Regulation on any scientific matter concerning the Centre'sactivities which the management board or the Director may submit toit.
The opinions of the Scientific Committee shall be published.2. The Scientific Committee shall consist of one representative from
each Member State. The management board may appoint up to sixother members having regard to their particular qualifications.
3. Members shall serve on the Scientific Committee for a three-year
period, which shall be renewable.
4. The Scientific Committee shall elect its chairman for a three-year
period.
5. The Scientific Committee shall be convened by its chairman at
least once a year.
Article 11
Drawingupofthebudget
1. Estimates of all the revenue and expenditure of the Centre shall
be prepared for each financial year, corresponding to the calendaryear, and shall be shown in the budget of the Centre.
2. The revenue and expenditure shown in the budget shall be in
balance.
3. The Centre's revenue shall, without prejudice to other resources,
consist of a subsidy from the Community entered in the general budgetof the European Union (Commission Section), payments for servicesrendered and any financial contributions from the organisations andbodies and non-Community countries mentioned in Articles 12 and 13
respectively.
4. The Centre's expenditure shall include:
(a) staff remuneration, administrative and infrastructure expenses, and
operating costs;1993R0302 — EN — 01.10.2003 — 003.001 — 8
▼M3
▼B
▼M3
▼M3
(b) expenditure in support of the national information networks which
form part of the Reitox network and expenditure relating tocontracts with the specialised centres.
5. Each year the Management Board, on the basis of a draft drawn
up by the Director, shall produce an estimate of revenue and expendi-
ture for the Centre for the following financial year. This estimate,which shall include a draft establishment plan, shall be forwarded bythe Management Board to the Commission by 31 March at the latest,together with the Centre's work programme.
6. The estimate shall be forwarded by the Commission to the
European Parliament and the Council (hereinafter referred to as the
‘budgetary authority’) together with the preliminary draft generalbudget of the European Union.
7. On the basis of the estimate, the Commission shall enter in the
preliminary draft general budget of the European Union the estimatesit deems necessary for the establishment plan and the amount of thesubsidy to be charged to the general budget, which it shall place before
the budgetary authority in accordance with Article 272 of the Treaty.
8. The budgetary authority shall authorise the appropriations for the
subsidy to the Centre.
The budgetary authority shall adopt the establishment plan for the
Centre.
9. The budget shall be adopted by the Management Board. It shall
become final following final adoption of the general budget of theEuropean Union. Where appropriate, it shall be adjusted accordingly.
10. The Management Board shall, as soon as possible, notify the
budgetary authority of its intention to implement any project which
may have significant financial implications for the funding of thebudget, in particular any projects relating to property such as the rentalor purchase of buildings. It shall inform the Commission thereof.
Where a branch of the budgetary authority has notified its intention to
deliver an opinion, it shall forward its opinion to the ManagementBoard within a period of six weeks from the date of notification of
the project.
Article 11a
Implementationofthebudget
1. The Director shall implement the budget of the Centre.2. By 1 March, at the latest, following each financial year, the
Centre's accounting officer shall communicate the provisional accounts
to the Commission's accounting officer together with a report on thebudgetary and financial management for that financial year. TheCommission's accounting officer shall consolidate the provisionalaccounts of the institutions and decentralised bodies in accordancewith Article 128 of the general Financial Regulation.
3. By 31 March at the latest following each financial year, the
Commission's accounting officer shall forward the Centre's provisional
accounts to the Court of Auditors, together with a report on thebudgetary and financial management for that financial year. The reporton the budgetary and financial management for the financial year shallalso be forwarded to the European Parliament and to the Council.
4. On receipt of the Court of Auditors' observations on the Centre's
provisional accounts, pursuant to Article 129 of the general Financial
Regulation, the Director shall draw upthe Centre's final accounts underhis own responsibility and submit them to the Management Board foran opinion.
5. The Management Board shall deliver an opinion on the Centre's
final accounts.
6. The Director shall, by 1 July at the latest following each financial
year, forward the final accounts to the European Parliament, the1993R0302 — EN — 01.10.2003 — 003.001 — 9
▼M3
Council, the Commission and the Court of Auditors, together with the
Management Board's opinion.
7. The final accounts shall be published.8. The Director shall send the Court of Auditors a reply to its obser-
vations by 30 September at the latest. He shall also send this reply to
the Management Board.
9. The Director shall submit to the European Parliament, at the
latter's request, any information required for the smooth application ofthe discharge procedure for the financial year in question, as laid downin Article 146(3) of the general Financial Regulation.
10. The European Parliament, on a recommendation from the
Council acting by a qualified majority, shall, before 30 April of year
N + 2, give a discharge to the Director in respect of the implementationof the budget for year N.
11. The financial rules applicable to the Centre shall be adopted by
the Management Board after the Commission has been consulted. Theymay not depart from Commission Regulation (EC, Euratom) No 2343/
2002 of 19 November 2002 on the framework Financial Regulation for
the bodies referred to in Article 185 of Council Regulation (EC,Euratom) No 1605/2002 on the Financial Regulation applicable to thegeneral budget of the European Communities (
1) unless specifically
required for the Centre's operation and with the Commission's prior
consent.
Article 12
Cooperationwithotherorganizationsandbodies
Without prejudice to relations which the Commission may maintain
pursuant to Article 229 of the Treaty, the Centre shall actively seekthe cooperation of international organizations and other, particularlyEuropean, governmental and non-governmental agencies competent in
the sector of drugs.
Article 13
Non-Communitycountries
1. The Centre shall be open to the participation of those non-
Community countries which share the Community's interests and thoseof its Member States in the Centre's objectives and work, on the basisof agreements entered into between them and the Community on thebasis of Article 235 of the Treaty.
2. The management board may take a decision on the involvement
of experts proposed by non-Community countries in the ad hoc
working parties provided for in Article 2 (2), subject to an undertaking
from the interested parties to observe the rules referred to in Article 6.
Article 14
Privileges andimmunities
The Protocol on the Privileges and immunities of the European
Communities shall apply to the Centre.
Article 15
StaffRegulations
The staff of the Centre shall be subject to the regulations and rules
applicable to the officials and other servants of the European Commu-nities.1993R0302 — EN — 01.10.2003 — 003.001 — 10
(1) OJ L 357, 31.12.2002, p. 72, with Corrigendum in OJ L 2, 7.1.2003, p. 39.▼B
▼B
The Centre shall exercise in respect of its staff the powers devolved to
the appointing authority.
The management board shall, in agreement with the Commission,
adopt the appropriate implementing rules.
Article 16
Liability
1. The contractual liability of the Centre shall be governed by the
law applicable to the contract in question. The Court of Justice shall
have jurisdiction pursuant to an arbitration clause contained in acontract concluded by the Centre.
2. In the case of non-contractual liability, the Centre shall, in accor-
dance with the general principles common to the laws of the MemberStates, make good any damage caused by the Centre or its servants inthe performance of their duties. The Court of Justice shall have juris-
diction in disputes relating to compensating for any such damage.
3. The personal liability of servants towards the Centre shall be
governed by the provisions applying to the staff of the Centre.
Article 17
JurisdictionfotheCourtofJustice
The Court of Justice shall have jurisdiction in actions brought against
the Centre under the conditions provided for in Article 173 of theTreaty.
Article 18
Report
During the third year following the entry into force of this Regulation,
the Commission shall forward to the European Parliament and to theCommunity a progress report on the Centre's activities, together with
proposals, if appropriate, to modify or extend its tasks, taking into
account, in particular, the evolution of Community powers.
Article 19
Entryintoforce
This Regulation shall enter into force on the day following the decision
of the competent authorities on the seat of the Centre.
This Regulation shall be binding in its entirety and directly applicable
in all Member States.1993R0302 — EN — 01.10.2003 — 003.001 — 11
▼B
ANNEX
A. The work of the Centre shall be carried out with due regard to the respective
powers of the Community and its Member States in the area of drugs, as
those powers are defined by the Treaty.
The information gathered by the Centre shall relate to the following priority
areas:
1. demand and reduction of the demand for drugs;
2. national and Community strategies and policies (with special emphasis on
international, bilateral and Community policies, action plans, legislation,
activities and agreements);
3. international cooperation and geopolitics of supply (with special emphasis
on cooperation programmes and information on producer and transit
countries);
4. control of trade in narcotic drugs, psychotropic substances and precursors,
as provided for in the relevant present or future international conventions
and Community acts (1);
5. Implications of the drugs phenomenon for producer, consumer and transit
countries, within areas covered by the Treaty, including money laun-
dering, as laid down by the relevant present or future Community acts (2).
B. The Commission shall make available to the Centre, for dissemination, the
information and statistical data which it possesses pursuant to its powers.
C. During the first three-year period special attention will be given to demand
and demand reduction.1993R0302 — EN — 01.10.2003 — 003.001 — 12
(1) — The relevant international conventions currently in force include, in particular, the
United Nations Conventions, in so far as the Community is or could become partyto them.
— The relevant Community acts currently in force include in particular Council Regu-
lation (EEC) No 3677/90 of 13 December 1990 laying down measures to be takento discourage the diversion of certain subtances to the illicit manufacture ofnarcotic drugs and psychotropic substances.
— This involves only information which the Member States are obliged to supply to
the Commission on the basis of existing and future Community legislation.
(
2) — Of the relevant Community acts currently in force the one concerning money laun-
dering is the Council Directive of 10 June 1991 on prevention of the use of thefinancial system for the purpose of money laundering.
— This involves only information which the Member States are obliged to supply to
the Commission on the basis of existing and future Community legislation.